Mandate

Vinge advises Infranity in connection with the acquisition of Nordic Re-Finance AB

Vinge has advised Infranity, a private equity firm specializing in infrastructure investments, in connection with its acquisition of a majority stake in Nordic Re-Finance AB, a Scandinavian locomotives lessor. The acquisition brings ambitious development plans for Nordic Re-Finance AB, including expansion into new geographical areas.

The transaction is subject to regulatory approvals and is expected to close in Q1 2025.

Vinge’s team consisted of among other Matthias Pannier, Ulrich Ziche, Robin Sultani and Sara Hammond (M&A), Calle Tengwall Pagels and Julia Gudmundsson (Banking and Finance, Jolene Reimerson, Christoffer Nordin, Katja Häglund and Nicklas Thorgerzon (Commercial Contracts, IT and GDPR), Victor Ericsson, Erik Kochbati, Tobias Fleischer, Ellenor Eckerborn and Marcus Svärd (Tax), Alice Göransson and Gulestan Ali (Employment), Tobias Kempas and Rebecka Målquist (IP), Daniel Wendelsson, Alva Chambert and Martin Hammarskiöld (FDI) and Julia Ulander Kull (Transaction Support).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025